Jeff Boyd was named vice president, chief scientific officer and director of the Cancer Institute’s Center for Genomic Medicine at The Northwell Health Cancer Institute. He will also hold an appointment as professor and member of the Cold Spring Harbor Laboratory Cancer Center.
As the Galleri test is advancing toward becoming the first multi-cancer detection test to secure FDA approval, cancer care providers are coming up with strategies for using these tests responsibly.
